Article Text

Download PDFPDF
Prolonged treatment with Tadekinig alfa in adult-onset Still’s disease

Statistics from Altmetric.com

Footnotes

  • Handling editor Josef S Smolen

  • Contributors All authors took part in drafting and revising the manuscript. CG-G performed the free IL-18 assays and drew figure 1. All authors approved the submitted version of the article.

  • Funding This study was funded by AB2 Bio.

  • Competing interests CG-G’s salary was supported by an unrestricted grant from AB2 Bio. EJS is an employee of AB2 Bio. CG has received consultant fees and a research grant from AB2 Bio and owns shares in AB2 Bio. All other authors have declared no conflicts of interest.

  • Patient consent Not required.

  • Ethics approval Geneva Ethics Committee on Research Involving Humans.

  • Provenance and peer review Not commissioned; internally peer reviewed.

  • Data sharing statement Should readers be interested in getting some additional unpublished data, they are asked to contact the authors.

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.